SRI, Amylyx Pharmaceuticals partner to identify ALS drug candidates

SRI and Amylyx Pharmaceuticals enter into a new research partnership to identify new drug candidates for amyotrophic lateral sclerosis. Credit: Sunnybrook Health Sciences Centre.